Mauritius
Tuberculosis profile
Population  2013 1.2 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.015 (0.015–0.015) 1.2 (1.2–1.2)
Mortality (HIV+TB only) 0.019 (0.015–0.023) 1.5 (1.2–1.9)
Prevalence  (includes HIV+TB) 0.39 (0.21–0.63) 32 (17–51)
Incidence  (includes HIV+TB) 0.26 (0.23–0.29) 21 (19–24)
Incidence (HIV+TB only) 0.048 (0.043–0.054) 3.8 (3.4–4.3)
Case detection, all forms (%) 50 (44–56)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0 (0–3.1) 0 (0–60)
MDR-TB cases among notified pulmonary
TB cases
0 (0–4) 0 (0–2)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 118   4
Pulmonary, clinically diagnosed 2   0
Extrapulmonary 6   0
       
Total new and relapse 130    
Previously treated, excluding relapses 0    
Total cases notified 130    
Among 130 new and relapse cases:
1 (<1%) cases aged under 15 years; male:female ratio: 2.3
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 118 (100%) 4 (100%) 122
Laboratory-confirmed RR-/MDR-TB cases     1
Patients started on MDR-TB treatment     0
TB/HIV 2013 Number (%)
TB patients with known HIV status 125 (96)
HIV-positive TB patients 23 (18)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 23 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 23 (100)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 91
Previously treated cases, excluding relapse, registered in 2012 100
HIV-positive TB cases, all types, registered in 2012 40
RR-/MDR-TB cases started on second-line treatment in 2011 100
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, outside
country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-08-30 Data: www.who.int/tb/data